Dabigatran

Drug Details

Dabigatran, marketed under the brand name Pradaxa, is a blood-thinning medication used to prevent and treat various types of blood clots. It is primarily prescribed for individuals with a specific type of irregular heartbeat known as atrial fibrillation (AFib), which is not caused by heart valve problems, to reduce the risk of stroke and harmful clots. Additionally, Dabigatran is effective in treating blood clots in the legs (deep vein thrombosis, DVT) or lungs (pulmonary embolism, PE) and is used to decrease the likelihood of these clots recurring. It is also administered after hip replacement surgery to prevent clot formation. The medication functions as an anticoagulant by directly inhibiting thrombin, a protein crucial for blood clotting. By blocking thrombin, Dabigatran helps maintain smooth blood flow and reduces the risk of clot-related complications. Typically taken orally twice daily, it may cause side effects such as stomach upset and bleeding. In cases of severe bleeding, an antidote called Praxbind (idarucizumab) is available to counteract its effects. Dabigatran is not suitable for preventing blood clots following artificial heart valve replacement. Patients who have undergone heart valve surgery should consult their healthcare provider for appropriate treatment options. It is crucial not to discontinue Dabigatran or any other medication without professional medical advice. Always consult a doctor, nurse, or pharmacist for personalized medical guidance.